IRE favicon


Resource ID: #28741
Subject: Drugs
Source: Anna Endey, Susan Berfield, Evelyn Yu, Ari Altstedter and Margaret Newkirk
Affiliation: Bloomberg
Date: September - December 2019



A series of Bloomberg stories showed how over-matched and under-resourced regulators at the FDA failed to uncover, trace or stop the spread of cancerous toxins. Even when aware of the problem, the agency was slow to respond and in some cases resistant to warning the public. Delving into the source of these pills, Bloomberg reporters documented how suppliers in China, India and even the U.S. not only cut corners to keep costs down but hid test results that would have shown the consequences of that cost-cutting.

141 Neff Annex   |   Missouri School of Journalism Columbia, MO 65211   |   573-882-2042   |   |   Privacy Policy
apartmentpenciluserscalendar-fullcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram